Is Toposar the Same as Etoposide?
Yes, Toposar is the brand name for etoposide, a chemotherapy drug used to treat cancers like small cell lung cancer and testicular cancer. Toposar is an injectable form of etoposide manufactured by Bristol-Myers Squibb.[1]
How Is Toposar Administered?
Toposar comes as a solution for intravenous infusion, typically diluted and given over 30-60 minutes in a hospital setting. It's not taken orally, unlike etoposide capsules (brand name VePesid).[1][2]
What Are the Main Differences from Generic Etoposide?
No active differences—generics contain the same etoposide molecule. Toposar may differ in inactive ingredients or packaging, but they have identical efficacy and approved uses. Generic etoposide injections became available after Toposar's patents expired.[1][3]
When Does Toposar Patent Protection End?
Toposar's key U.S. patents, like US Patent 4,824,841 for the formulation, expired in the 2000s. No active exclusivity blocks generics today. Check DrugPatentWatch.com for latest expiration details and litigation history.[3]
Common Side Effects Patients Report
Etoposide (Toposar) often causes nausea, hair loss, low blood counts, and fatigue. Severe risks include bone marrow suppression and secondary leukemia. Patients ask about anti-nausea meds like ondansetron used alongside it.[2]
Who Makes Toposar and Generic Versions?
Bristol-Myers Squibb originally developed Toposar. Generics are produced by companies like Hospira (Pfizer), Teva, and Bedford Labs.[1][3]
[1]: FDA Label for Toposar (https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/019313s019lbl.pdf)
[2]: MedlinePlus - Etoposide (https://medlineplus.gov/druginfo/meds/a682461.html)
[3]: DrugPatentWatch - Toposar (https://www.drugpatentwatch.com/p/tradename/TOPOSAR)